Promoter group
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$1365.8B
Focus Areas
10
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Aurobindo Pharma | $750.4B |
| Glenmark Pharmaceuticals | $615.4B |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Aurobindo Pharma | $750.4B |
| Glenmark Pharmaceuticals | $615.4B |